These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1230 related items for PubMed ID: 26584195

  • 1. Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial.
    Shakoory B, Carcillo JA, Chatham WW, Amdur RL, Zhao H, Dinarello CA, Cron RQ, Opal SM.
    Crit Care Med; 2016 Feb; 44(2):275-81. PubMed ID: 26584195
    [Abstract] [Full Text] [Related]

  • 2. Is Interleukin-1 Receptor Blockade Ready for Prime Time in Patients With Severe Sepsis and Macrophage Activation Syndrome?
    Johnson DW, Kalil AC.
    Crit Care Med; 2016 Feb; 44(2):443-4. PubMed ID: 26771789
    [No Abstract] [Full Text] [Related]

  • 3. Serum thrombomodulin level relates to the clinical course of disseminated intravascular coagulation, multiorgan dysfunction syndrome, and mortality in patients with sepsis.
    Lin SM, Wang YM, Lin HC, Lee KY, Huang CD, Liu CY, Wang CH, Kuo HP.
    Crit Care Med; 2008 Mar; 36(3):683-9. PubMed ID: 18431261
    [Abstract] [Full Text] [Related]

  • 4. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group.
    Fisher CJ, Dhainaut JF, Opal SM, Pribble JP, Balk RA, Slotman GJ, Iberti TJ, Rackow EC, Shapiro MJ, Greenman RL.
    JAMA; 1994 Jun 15; 271(23):1836-43. PubMed ID: 8196140
    [Abstract] [Full Text] [Related]

  • 5. Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock.
    Angstwurm MW, Engelmann L, Zimmermann T, Lehmann C, Spes CH, Abel P, Strauss R, Meier-Hellmann A, Insel R, Radke J, Schüttler J, Gärtner R.
    Crit Care Med; 2007 Jan 15; 35(1):118-26. PubMed ID: 17095947
    [Abstract] [Full Text] [Related]

  • 6. Role of interleukin-1 and the therapeutic potential of interleukin-1 receptor antagonist in sepsis.
    Fisher CJ, Opal SM, Lowry SF, Sadoff JC, LaBrecque JF, Donovan HC, Lookabaugh JL, Lemke J, Pribble JP, Stromatt SC.
    Circ Shock; 1994 Sep 15; 44(1):1-8. PubMed ID: 7704933
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Early Detection of Disseminated Intravascular Coagulation During Septic Shock: A Multicenter Prospective Study.
    Delabranche X, Quenot JP, Lavigne T, Mercier E, François B, Severac F, Grunebaum L, Mehdi M, Zobairi F, Toti F, Meziani F, Boisramé-Helms J, on behalf to the Clinical Research in Intensive Care and Sepsis Network.
    Crit Care Med; 2016 Oct 15; 44(10):e930-9. PubMed ID: 27322364
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Persistent organ dysfunction after severe sepsis: a systematic review.
    Guirgis FW, Khadpe JD, Kuntz GM, Wears RL, Kalynych CJ, Jones AE.
    J Crit Care; 2014 Jun 15; 29(3):320-6. PubMed ID: 24360598
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 62.